Your browser doesn't support javascript.
loading
Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA-1 Trial.
Wang, Yuhuan; Nguyen, Jenny-Hoa; de Ruiter, Ruben D; Mendell, Jeanne; Srinivasan, Dushyanth; Davis, John D; Eekhoff, E Marelise W.
Afiliación
  • Wang Y; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Nguyen JH; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • de Ruiter RD; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers (UMC), Vrije Universiteit, Amsterdam UMC Expert Center in Rare Bone Disease, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
  • Mendell J; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Srinivasan D; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Davis JD; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Eekhoff EMW; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers (UMC), Vrije Universiteit, Amsterdam UMC Expert Center in Rare Bone Disease, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
J Clin Pharmacol ; 64(2): 264-274, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37694449
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacología Clínica / Miositis Osificante Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacología Clínica / Miositis Osificante Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos